BDBM387163 2-{(3aR, 7aR)-6-[(2-pyrimidin-2- ylphenyl)carbonyl]octahydro-1H- pyrrolo[2,3-c]pyridin-1-yl}pyridine-4- carbonitrile::US9938276, E23

SMILES O=C(N1CC[C@H]2CCN([C@H]2C1)c1cc(ccn1)C#N)c1ccccc1-c1ccccc1

InChI Key InChIKey=VXNOYNXYRVFOPX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387163   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387163(2-{(3aR, 7aR)-6-[(2-pyrimidin-2- ylphenyl)carbonyl...)
Affinity DataIC50: 99.5nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387163(2-{(3aR, 7aR)-6-[(2-pyrimidin-2- ylphenyl)carbonyl...)
Affinity DataIC50: 1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent